Literature DB >> 32621997

Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?

Anunay Gupta1, Jyothi Vijay2, Sourabh Agstam3.   

Abstract

Entities:  

Keywords:  Bazett; Framingham; Fridericia; Hydroxychloroquine; QTc correction; Torsades de Pointes

Year:  2020        PMID: 32621997      PMCID: PMC7327452          DOI: 10.1016/j.ipej.2020.06.008

Source DB:  PubMed          Journal:  Indian Pacing Electrophysiol J        ISSN: 0972-6292


× No keyword cloud information.
Letter to the editor Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation? World Health Organisation has declared COVID-19 as pandemic on March 11, 2020. Hydroxychloroquine has been recommended for treatment as well as prophylaxis for health care workers by Indian Council of Medical research for COVID -19 [1]. Hydroxychloroquine is an analogue of chloroquine. It is more potent and have fewer drug interactions when compared with chloroquine. The intrinsic property of hydroxychloroquine on the sinoatrial node cannot be overlooked. It slows the rate of sinus node by inhibiting L-type calcium channels (ICaL), rapid delayed rectifier potassium current (Ikr), and funny channels (If) [2]. Although it is a safe drug, one of the serious adverse effects is QT prolongation, culminating in Torsade des Pointes, leading to sudden cardiac death. The recent guidelines released by Indian Heart Rhythm Society on hydroxychloroquine recommended the use of Bazett formula for calculation of QTc prolongation [3]. As we know, there are multiple formulae for calculating QTc - Bazett, Fridericia, Framingham, and Hodges. Framingham linear regression equation is the appropriate for calculating QTc for epidemiological purposes, as it is derived from large population sample [4]. Unfortunately, there are no large studies to show the benefit of using one formulae over the other in predicting torsades de pointes. The study by Vanderberk and coworkers in drug-induced QTc prolongation advocated using Fridericia or Framingham formula, instead of Bazett formula, which may undercorrects QTc prolongation at low heart rate and overcorrects at high heart rate [5]. Due to the bradycardic effect of hydroxychloroquine, Bazett formula should not be used for calculating QTc in the COVID-19 pandemic. Further large studies are required to look for the effectiveness of various QTc correction formulae in this COVID-19 pandemic.
  4 in total

Review 1.  What clinicians should know about the QT interval.

Authors:  Sana M Al-Khatib; Nancy M Allen LaPointe; Judith M Kramer; Robert M Califf
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

2.  Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential.

Authors:  Rebecca A Capel; Neil Herring; Manish Kalla; Arash Yavari; Gary R Mirams; Gillian Douglas; Gil Bub; Keith Channon; David J Paterson; Derek A Terrar; Rebecca-Ann B Burton
Journal:  Heart Rhythm       Date:  2015-05-27       Impact factor: 6.343

3.  Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.

Authors:  Aditya Kapoor; Ulhas Pandurangi; Vanita Arora; Anoop Gupta; Aparna Jaswal; Ashish Nabar; Ajay Naik; Nitish Naik; Narayanan Namboodiri; Amit Vora; Rakesh Yadav; Anil Saxena
Journal:  Indian Pacing Electrophysiol J       Date:  2020-04-08

4.  Which QT Correction Formulae to Use for QT Monitoring?

Authors:  Bert Vandenberk; Eline Vandael; Tomas Robyns; Joris Vandenberghe; Christophe Garweg; Veerle Foulon; Joris Ector; Rik Willems
Journal:  J Am Heart Assoc       Date:  2016-06-17       Impact factor: 5.501

  4 in total
  2 in total

1.  Waiting for Godot: A cross sectional survey based analysis of the hydroxychloroquine prophylaxis strategy against COVID-19 in India.

Authors:  Merlin Moni; Thushara Madathil; Rahul Palabatla; Sabarish Balachandran; Fabia Edathadathil; Georg Gutjahr; Sai B Madathil; Rajesh Pai; Beena Kv; Aveek Jayant; Dipu T Sathyapalan
Journal:  J Public Health Res       Date:  2020-12-30

2.  Reply to letters regarding our paper "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Societyˮ.

Authors:  Aditya Kapoor; Ulhas Pandurangi; Vanita Arora; Anoop Gupta; Aparna Jaswal; Ashish Nabar; Ajay Naik; Nitish Naik; Narayanan Namboodiri Kk; Amit Vora; Rakesh Yadav; Anil Saxena
Journal:  Indian Pacing Electrophysiol J       Date:  2020-07-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.